For example, loss‐of‐function mutations in MAP3K1 and MAP2K4, two kinases involved in activation of JNK, are most commonly found in luminal breast cancer of which approximately 15% contain mutations in either gene (Cancer Genome Atlas Network, 2012). Here, MAP2K4 is linked to breast carcinoma.